Sort
17,828 grants matching “crispr”
CRISPR-Image Core
$400,396Adam David Hoppe · South Dakota State University · P20 · FY2024 · GM
SHP1 Phosphatase/SYK Kinase Balance Controls the Actin Economy and Macropinocytosis in Macrophages
$400,395Natalie Wendt Thiex · South Dakota State University · P20 · FY2024 · GM
Primary Cilia-Dependent Mechanisms of Lymphangiogenesis
$400,394Darci M. Fink · South Dakota State University · P20 · FY2024 · GM
Multimodality Molecular Imaging of Stem Cell Therapy for Ischemic Cardiomyopathy
$400,332Patricia Kim Phuong Nguyen · Stanford University · R01 · FY2021 · HL
Role of newly identified, thyroid-specific LincRNA in BRAFV600E thyroid carcinoma
$400,313Carmelo Nucera · Beth Israel Deaconess Medical Center · R01 · FY2020 · CA
Role of newly identified, thyroid-specific LincRNA in BRAFV600E thyroid carcinoma
$400,313Carmelo Nucera · Beth Israel Deaconess Medical Center · R01 · FY2021 · CA
Genome Editing by Homologous Recombination to Create HIV Resistant Immune System
$400,267Matthew H Porteus · Stanford University · R01 · FY2016 · AI
Co-targeting S6 and TAM kinases in PTEN-deficient glioblastoma
$400,209David R Plas · University Of Cincinnati · R01 · FY2024 · CA
Somatic Repeat Expansions as a Therapeutic Target for Trinucleotide Repeat Disorders
$400,178Ricardo Mouro Pinto · Massachusetts General Hospital · R01 · FY2024 · NS
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
$400,139Dirk P Dittmer · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
$400,137Dirk P Dittmer · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Manipulation of innate immunity by Polyomavirus T antigens
$400,127James M Pipas · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
Manipulation of innate immunity by Polyomavirus T antigens
$400,127James M Pipas · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
$400,103Dirk P Dittmer · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
$400,103Dirk P Dittmer · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Mechanistic insights into the role of mitochondrial iron in doxorubicin-induced cardiomyopathy using human induced pluripotent stem cells
$400,000Hossein Ardehali · Northwestern University At Chicago · R01 · FY2023 · HL
Mechanisms of second heart field development regulated by Nkx genes
$400,000Kimara L. Targoff · Columbia University Health Sciences · R01 · FY2018 · HL
The Immunosuppressive Function of Checkpoint Kinase 2 in Gliomas
$400,000Crismita Clement Dmello · Northwestern University At Chicago · R01 · FY2025 · NS
The immunosuppressive function of Checkpoint kinase 2 in gliomas
$400,000Crismita Clement Dmello · Northwestern University At Chicago · R01 · FY2024 · NS
ER-to-Golgi transport of coagulation factors V and VIII
$400,000Bin Zhang · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · HL
Mechanisms of second heart field development regulated by Nkx genes
$400,000Kimara L. Targoff · Columbia University Health Sciences · R01 · FY2017 · HL
Mechanistic insights into the role of mitochondrial iron in doxorubicin-induced cardiomyopathy using human induced pluripotent stem cells
$400,000Hossein Ardehali · Northwestern University At Chicago · R01 · FY2022 · HL
Identifying transcriptomic and epigenomic convergence in intellectual and developmental disorders
$400,000Ryan Dhindsa · Baylor College Of Medicine · DP5 · FY2024 · OD
Engineering next generation supercharged CAR T-cells against solid tumors
$400,000Premal Patel · Cellinfinity Bio, Inc. · R43 · FY2023 · CA
Identifying transcriptomic and epigenomic convergence in intellectual and developmental disorders
$400,000Ryan Dhindsa · Baylor College Of Medicine · DP5 · FY2023 · OD